News

The Foundation for Barnes-Jewish Hospital’s commitment to building healthier and brighter futures for everyone extends beyond the hospital walls and into the community. The Foundation is proud to announce the distribution of $66,000 to three nonprofit organizations in the St. Louis region through its Community Support Grants Program.

The Foundation for Barnes-Jewish Hospital recently presented Michael Avidan, MBBCh, with its 2025 President's Achievement Award. Dr. Avidan leads WashU Medicine's Department of Anesthesiology as the chair of the WashU Medicine Department of Anesthesiology and anesthesiologist-in-chief at Barnes-Jewish Hospital.

Each year, the Foundation presents the President's Achievement Award to an accomplished physician, researcher, or faculty partner who upholds the Barnes-Jewish Hospital mission, advances medical knowledge, continuously improves the delivery of world-class patient care, and educates the next generation of clinicians.

Six resident physicians and fellows received Knowlton Incentive for Excellence Awards at The Foundation for Barnes-Jewish Hospital’s 41st annual award presentation on November 24, 2025. 

A recent Leading Edge Medicine event featured a panel of WashU Medicine and Barnes-Jewish Hospital cardiovascular experts. Drs. Gregory A. Ewald, Tsuyoshi Kaneko, and Nishath Quader discussed the future of cardiovascular care and the philanthropic investments that are transforming outcomes for patients with heart disease.

The Foundation for Barnes-Jewish Hospital is pleased to announce it has raised $2 million to establish PREVENT, a multidisciplinary program at WashU Medicine and Barnes-Jewish Hospital focused on prevention and early detection of stomach and pancreatic cancers.

When Tsuyoshi Kaneko, MD, arrived as the chief of cardiac surgery at WashU Medicine and Barnes-Jewish Hospital in October 2022, he delivered a bounty of innovations for patients like Harry Ratliff.

Inflammatory breast cancer (IBC) is a rare but highly aggressive cancer that progresses very quickly, often over the course of days or weeks.

Thanks to ongoing donor support through The Foundation for Barnes-Jewish Hospital, WashU Medicine researchers are making progress on better ways to tackle triple-negative breast cancer (TNBC).

In the future, some low-risk breast tumors may be removed through cryoablation, thanks to a donor-funded study led by Julie Margenthaler, MD, FACS, director of Breast Surgical Services at Siteman Cancer Center and the inaugural Endowed Chair for Surgical Excellence in Breast Cancer through The Foundation for Barnes-Jewish Hospital. 

On September 18, 2025, The Foundation for Barnes-Jewish Hospital held the Nicholas T. Kouchoukos Research Day in partnership with the WashU Division of Cardiothoracic Surgery.